| Risk factors for COVID-19 J Rashedi, B Mahdavi Poor, V Asgharzadeh, M Pourostadi, ... Infez Med 28 (4), 469-474, 2020 | 256 | 2020 |
| Empagliflozin alleviates renal inflammation and oxidative stress in streptozotocin-induced diabetic rats partly by repressing HMGB1-TLR4 receptor axis ZA Jigheh, AG Haghjo, H Argani, L Roshangar, N Rashtchizadeh, ... Iranian journal of basic medical sciences 22 (4), 384, 2019 | 89 | 2019 |
| Vitamin D receptor gene polymorphism and vitamin D plasma concentration: correlation with susceptibility to tuberculosis J Rashedi, M Asgharzadeh, SR Moaddab, L Sahebi, M Khalili, M Mazani, ... Advanced pharmaceutical bulletin 4 (Suppl 2), 607, 2014 | 55 | 2014 |
| Anti-tumor effect of quercetin loaded chitosan nanoparticles on induced colon cancer in wistar rats J Rashedi, AG Haghjo, MM Abbasi, AD Tabrizi, S Yaqoubi, D Sanajou, ... Advanced pharmaceutical bulletin 9 (3), 409, 2019 | 47 | 2019 |
| FPS-ZM1 and valsartan combination protects better against glomerular filtration barrier damage in streptozotocin-induced diabetic rats MMA Davoud Sanajou, Amir Ghorbani Haghjo, Hassan Argani, Leila Roshangar ... Journal of Physiology and Biochemistry, 2018 | 31 | 2018 |
| Association of promoter polymorphisms of interleukin-10 and interferon-gamma genes with tuberculosis in Azeri population of Iran M Asgharzadeh, S Ghorghanlu, J Rashedi, BM Poor, F Khaki-Khatibi, ... Iranian Journal of Allergy, Asthma and Immunology, 167-173, 2016 | 28 | 2016 |
| Reduction of renal tubular injury with a RAGE inhibitor FPS-ZM1, valsartan and their combination in streptozotocin-induced diabetes in the rat D Sanajou, A Ghorbani Haghjo, H Argani, L Roshangar, N Rashtchizadeh, ... European Journal of Pharmacology, 2018 | 27 | 2018 |
| Multidrug-resistant tuberculosis in north-west of Iran and Republic of Azerbaijan: a major public health concern for Iranian people J Rashedi, BM Poor, A Rafi, M Asgharzadeh, J Abdolalizadeh, ... Journal of research in health sciences 15 (2), 101-103, 2015 | 23 | 2015 |
| Molecular characterization of Cryptosporidium species in children with diarrhea in north west of Iran BM Poor, J Rashedi, M Asgharzadeh, E Fallah, K Hatam-Nahavandi, ... International journal of molecular and cellular medicine 4 (4), 235, 2015 | 23 | 2015 |
| Cytotoxic effect of rosemary extract on gastric adenocarcinoma (AGS) and esophageal squamous cell carcinoma (KYSE30) cell lines N Karimi, J Rashedi, BM Poor, S Arabi, M Ghorbani, N Tahmasebpour, ... Gastroenterology and hepatology from bed to bench 10 (2), 102, 2017 | 21 | 2017 |
| Tuberculosis and diabetes mellitus in Northwest of Iran MA Ozma, J Rashedi, BM Poor, A Vegari, V Asgharzadeh, HS Kafil, ... Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2020 | 18 | 2020 |
| Laboratory Cross‑Contamination of Mycobacterium tuberculosis: A Systematic Review and Meta‑analysis A Barac, HK Esfahani, M Pourostadi, MT Rahimi, E Ahmadpour, ... Lung 197 (841), 1-11, 2019 | 16 | 2019 |
| Empagliflozin attenuates renal and urinary markers of tubular epithelial cell injury in streptozotocin-induced diabetic rats Z Ashrafi Jigheh, A Ghorbani Haghjo, H Argani, L Roshangar, ... Indian Journal of Clinical Biochemistry 35, 109-114, 2020 | 15 | 2020 |
| False-positive Mycobacterium tuberculosis detection: Ways to prevent cross-contamination M Asgharzadeh, MA Ozma, J Rashedi, BM Poor, V Agharzadeh, A Vegari, ... Tuberculosis and Respiratory Diseases 83 (3), 211, 2020 | 14 | 2020 |
| Vitamin supplementation as a potential adjunctive therapeutic approach for COVID-19: biological and clinical plausibility AD Sorkhabi, A Sarkesh, AD Sorkhabi, T Entezari-Maleki, J Rashedi, ... J Basic Clin Physiol Pharmacol, 2022 | 12 | 2022 |
| Laboratory diagnosis of COVID-19 M Asgharzadeh, MR Valiollahzadeh, BM Poor, HS Kafil, V Asgharzadeh, ... Clinical Pulmonary Medicine 27 (5), 148-153, 2020 | 11 | 2020 |
| Frequency of smear-negative tuberculosis in Northwest Iran M Mahya Pourostadi, J Rashedi, BM Poor, HS Kafil, ... Iranian Journal of Medical Sciences 43 (3), 269, 2018 | 11 | 2018 |
| HIV/AIDS in Iran HB Baghi, M Aghazadeh, J Rashedi, BM Poor Clinical Infectious Diseases 64 (6), 820-821, 2017 | 9 | 2017 |
| Tuberculosis control and role of molecular epidemiology studies in Iran: a systematic review M Pourostadi, J Rashedi, BM Poor, HS Kafil, A Kazemi, M Asgharzadeh Tanaffos 16 (3), 190, 2017 | 9 | 2017 |
| Molecular diversity of Mycobacterium tuberculosis strains in Northwestern Iran M Pourostadi, J Rashedi, BM Poor, HS Kafil, S Shirazi, M Asgharzadeh Jundishapur journal of microbiology 9 (9), 2016 | 7 | 2016 |
Mohammad AsgharzadehTabriz University of Medical SciencesEmail yang diverifikasi di tbzmed.ac.ir
